The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume.
Muhammad Ruhu Amin ShipaSu-Ann YeohAndrew Embleton-ThirskDev MukerjeeMichael R EhrensteinPublished in: Rheumatology (Oxford, England) (2021)
Our data provides mechanistic insight into the synergistic clinical benefit of concomitant hydroxychloroquine with methotrexate, boosting the rise in MCV which could serve as a companion biomarker of treatment response.